Monitoring and Predicting Response to Peptide Receptor Radionuclide Therapy: A Quantitative SPECT-CT Based Analysis~!2009-12-10~!2010-02-04~!2010-04-21~! [PDF]
Ponraj Chinnadurai+6 more
openalex +1 more source
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder+5 more
wiley +1 more source
Novel SDHD Gene Mutation (H102R) in a Patient With Metastatic Cervical Paraganglioma Effectively Treated by Peptide Receptor Radionuclide Therapy [PDF]
Thorsten D. Poeppel+8 more
openalex +1 more source
Evaluation of [18F]PSMA‐1007 uptake variability in patients with prostate cancer
Abstract Background The biodistribution of PSMA‐ligands is of interest in radionuclide therapy planning. We investigated the variability of [18F]PSMA‐1007 uptake in organs at risk and in relation to tumour burden in prostate cancer patients. Methods A total of 1086 patients who underwent PSMA PET‐CT for staging or recurrence of prostate cancer were ...
Elin Trägårdh+4 more
wiley +1 more source
Myocardial perfusion imaging in advanced coronary artery disease
Myocardial perfusion imaging in advanced coronary artery disease. This review focusses on the utility of MPI by means of CMR, SPECT and PET, in patients with advanced CAD—the latter characterized by documented CAD (i.e. MI and/or PCI, prior CABG or the presence of a CTO).
Roel Hoek+9 more
wiley +1 more source
The insertion of a fluorescent coumarin unit by using a lysine‐based linker on deferoxamine leads to a chelating agent (DFOKC), whose Cu(II) and Zr(IV) complexes can be used for both optical imaging and positron emission tomography. DFOKC shows increased binding ability for Cu(II) and Zr(II) and improved tumor cell internalization via pinocytosis ...
Yschtar Tecla Simonini Steiner+8 more
wiley +1 more source
A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β−-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative [PDF]
Cristina Müller+8 more
openalex +1 more source
<sup>212</sup>Pb in targeted radionuclide therapy: a review. [PDF]
Scaffidi-Muta JM, Abell AD.
europepmc +1 more source
Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT [PDF]
Joseph Grudzinski+9 more
openalex +1 more source